Multiple-risk intervention with single-pill amlodipine besylate/atorvastatin calcium therapy helps patients with diverse ethnicity attain recommended therapeutic goals for blood pressure and lipids (The GEMINI-AALA study)

被引:0
|
作者
Erdine, S.
Ro, Y.
Tse, H.
Howes, L.
Aguilar-Salinas, C.
Chaves, H.
Guindy, R.
Chopra, P.
Moller, R.
Schou, I.
机构
[1] Univ Istanbul, TR-34452 Istanbul, Turkey
[2] Korea Univ, Puchon, South Korea
[3] Griffith Univ, Gold Coast, Australia
[4] INCMNSZ, Mexico City, DF, Mexico
[5] Univ Fed Pernambuco, Boa Vista, Brazil
[6] Ain Shams Univ, Cairo, Egypt
[7] Pfizer Inc, New York, NY USA
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:S277 / S277
页数:1
相关论文
共 10 条
  • [1] Multiple-risk intervention with single-pill amlodipine/atorvastatin therapy helps patients with diverse ethnicity attain recommended therapeutic goals for blood pressure and lipids (the GEMINI-AALA study)
    Tse, Hung F.
    Ro, Young-Moo
    Howes, Laurie
    Aguilar-Salinas, Carlos
    Chaves, Hilton
    Erdine, Serap
    Guindy, Ramez
    Chopra, Pravin
    Moller, Robert A.
    Schou, I. Manjula
    JOURNAL OF HYPERTENSION, 2006, 24 : 329 - 329
  • [2] Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study)
    Erdine, S.
    Ro, Y. M.
    Tse, H-F
    Howes, L. G.
    Aguilar-Salinas, C. A.
    Chaves, H.
    Guindy, R.
    Chopra, P.
    Moller, R. A.
    Schou, I. M.
    JOURNAL OF HUMAN HYPERTENSION, 2009, 23 (03) : 196 - 210
  • [3] Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study)
    S Erdine
    Y M Ro
    H-F Tse
    L G Howes
    C A Aguilar-Salinas
    H Chaves
    R Guindy
    P Chopra
    R A Moller
    I M Schou
    Journal of Human Hypertension, 2009, 23 : 196 - 210
  • [4] Clinical utility of single-pill amlodipine besylate/atorvastatin calcium for the attainment of blood pressure and lipid goals in patients of diverse ethnicity with diabetes: Results from the GEMINI-AALA Study
    Aguilar-Salinas, C. A.
    Ro, Y.
    Tse, H.-F.
    Howes, L. G.
    Chaves, H.
    Erdine, S.
    Guindy, R.
    Chopra, P.
    Moller, R. A.
    Schou, I. M.
    DIABETOLOGIA, 2007, 50 : S478 - S478
  • [5] Clinical utility of single-pill amlodipine/atorvastatin for the attainment of blood pressure and lipid goals in diabetic patients of diverse ethnicity: Results from the GEMINI-AALA study
    Aguilar-Salinas, Carlos A.
    Tse, Hung-Fat
    Ro, Young Moo
    Howes, Laurence G.
    Chaves, Hilton
    Erdine, Serap
    Guindy, Ramez
    Chopra, Pravin
    Moller, Robert A.
    Schou, Ishani M.
    DIABETES, 2007, 56 : A547 - A547
  • [6] Utility of single-pill amlodipine besylate/atorvastatin calcium to help Asian patients with hypertension and dyslipidemia achieve blood pressure and lipid goals: Results of a pooled analysis
    Tse, Hung F.
    Blank, Roy
    Victor, Ronald
    Hobbs, Richard
    Shi, Harry
    Moller, Robert A.
    Schou, Ishani M.
    Gensini, Gianfranco
    Chopra, Pravin
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 58 - 58
  • [7] Clinical utility of single-pill amlodipine besylate/atorvastatin calcium to reduce predicted 10-year coronary heart disease risk by lowering blood pressure and lipids to meet therapeutic goals in Latin American patients with hypertension/dyslipidemia
    Chaves, H.
    Ro, Y.
    Tse, H. F.
    Howes, L.
    Aguilar-Salinas, C.
    Erdine, S.
    Guindy, R.
    Chopra, P.
    Moller, R. A.
    Schou, I. M.
    CIRCULATION, 2008, 118 (12) : E466 - E466
  • [8] Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial
    Grimm, Richard
    Malik, Mobin
    Yunis, Carla
    Sutradhar, Santosh
    Kursun, Attila
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 261 - 271
  • [9] Utility of single-pill amlodipine besylate/atorvastatin calcium for the control of blood pressure and low-density lipoprotein cholesterol in patients with and without diabetes: Results of a large pooled analysis
    Aguilar-Salinas, Carlos A.
    Jenssen, Trond G.
    Hobbs, Richard
    Feldman, Ross D.
    Blank, Roy C.
    Moller, Robert A.
    Schou, Ishani M.
    Shi, Harry
    DIABETES, 2008, 57 : A597 - A597
  • [10] Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction?: Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL program)
    Hobbs, F. D. Richard
    Gensini, Gianfranco
    Mancini, G. B. John
    Manolis, Athanasios J.
    Bauer, Beverly
    Boehler, Steffen
    Genest, Jacques
    Feldman, Ross
    Harvey, Peter
    Jenssen, Trond G.
    Metcalfe, Michael
    Marques da Silva, Pedro
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 110 (02) : 242 - 250